RefleXion Medical tapped security provider MedCrypt to encrypt data communicated through its radiation therapy device.
More than half of subjects who took the hydrogel particles lost weight, encouraging Gelesis to file for approval despite missing another endpoint.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
The FDA approved MR-conditional labeling for the Ellipse implantable cardioverter defibrillator.
Brainlab snagged a pair of FDA nods for its software that helps surgeons plan radiosurgery of the spine and the brain.
BioSensics picked up more than $2.5 million in an NIH grant to develop a remote monitoring device for Huntington disease.
Getting the FDA nod positions Cefaly to expand use of its external trigeminal nerve stimulation device beyond preventative situations.
The FDA has cleared Arkis BioSciences’ catheter that relieves high brain pressure and other conditions by draining cerebrospinal fluid.
Here is Wednesday's medtech news of note.
With a CE mark, Mazor and distribution partner Medtronic may now enter the European market.
A 20-patient study showed its ultrasound PAD balloon was effective in patients with arterial blockage below the knee.